Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
UBS
Harvard Business School
Johnson and Johnson
Mallinckrodt
Cantor Fitzgerald
AstraZeneca
Queensland Health
Deloitte

Generated: April 23, 2018

DrugPatentWatch Database Preview

XENAZINE Drug Profile

« Back to Dashboard

Which patents cover Xenazine, and what generic alternatives are available?

Xenazine is a drug marketed by Valeant Pharms North and is included in one NDA.

The generic ingredient in XENAZINE is tetrabenazine. There are twelve drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the tetrabenazine profile page.
Drug patent expirations by year for XENAZINE
Medical Subject Heading (MeSH) Categories for XENAZINE
Synonyms for XENAZINE
1,2,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one
1,3,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo(a)quinolizin-2-one
1,3,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one
1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-Benzo[a]quinolizin-2-one
1,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one
2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine
2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7,11b-hexahydro-2H-benzo(a)quinolizine
2-Oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11-beta-hexahydro-2H-benzoquinolizine
2-Oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11.beta.-hexahydro-2H-benzoquinolizine
2-oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine
2-Oxo-3-isobutyl-9,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine
2-Oxo-3-isobutyl-9,3,4,6,7,11.beta.-hexahydro-2H-benzoquinolizine
2,3-dimethoxy-9-(2-methylpropyl)-5,6,7,11a-tetrahydropiperidino[2,1-a]isoquino lin-10-one
2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-
2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-
2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-(9CI)
2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7, 11b-hexahydro-3-isobutyl-9,10-dimethoxy-,
2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-
2h-benzo[a]quinolizin-2-one,1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-,(3r,11br)-rel
2H-Benzo[a]quinolizin-2-one,1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-,(3R,11bR)-rel-
2H-Benzo[a]quinolizin-2-one,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-
2H-Benzo[a]quinolizin-2-one,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-
3-isobutyl-9-,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizin-2-one
3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizin-2-one
3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one
3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one #
3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-pyrido[2,1-a]isoquinolin-2-one
3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one
3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one
58-46-8
718635-93-9
9,10-Dimethoxy-1,3,4,6,7,11b-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one
9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one
9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one
9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-one
9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one
A2708/0115225
AB0073774
AB2000294
AC1L1LMF
ACT06890
AI3-52046
AK141500
AKOS001681311
AKOS016347602
AN-41756
API0004368
AX8281672
BC201335
BDBM50017701
BN0515
BRD-A47564106-001-01-8
BRN 0040090
C11168
CAS-58-46-8
CCG-118217
CHEBI:64028
CHEMBL117785
CS-5700
CTK8E8809
D08575
D09PJX
DB04844
DSSTox_CID_22614
DSSTox_GSID_42614
DSSTox_RID_80059
DTXSID0042614
EINECS 200-383-6
FT-0674921
FT-0700948
GTPL4834
HMS1540E17
HMS2966E06
HMS3263I14
HMS3430F03
HY-B0590A
KB-3357051
KS-00001F7Q
LP01086
LS-40294
MCULE-5822627411
MFCD00042740
MFCD08461052
MKJIEFSOBYUXJB-UHFFFAOYSA-N
MLS001249426
MLS001249497
MLS003106727
MolPort-002-712-672
NCGC00160421-01
NCGC00160421-02
NCGC00160421-03
NCGC00261771-01
Nitoman
Nitoman (TN)
Nitoman, Xenazine, Tetrabenazine
Nitoman;Xenazine
NSC 169886
NSC-169886
NSC-172187
NSC169886
NSC172187
Oprea1_264344
PB21652
PL005944
PL030555
Q-2641
Revocon
Ro 1-9569
Ro 1-9569/12
Ro-19569
Rubigen
s1789
SBB018797
SC-20416
SCHEMBL62026
SMR000718664
SR-01000833864
SR-01000833864-4
ST028814
STK678061
TC-062470
tetra Benazin
Tetrabenazin
Tetrabenazina
Tetrabenazina [INN-Spanish]
TETRABENAZINE
Tetrabenazine (INN)
Tetrabenazine (JAN/INN)
Tetrabenazine (Nitoman, Xenazine)
Tetrabenazine (Racemate)
Tetrabenazine [INN:BAN]
Tetrabenazine, racemic mixture|||9,10-Dimethoxy-1,3,4,6,7,11b-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one
Tetrabenazine(Racemate)
Tetrabenazinum
Tetrabenazinum [INN-Latin]
Tetrabenzaine
Tetrabenzine
TimTec1_002217
TL8005032
Tox21_111803
Tox21_111803_1
Tox21_501086
WLN: T B666 DV GNTT&J E1Y1&1 LO1 MO1
Xenazine (TN)
Z1563146114
Z3433

US Patents and Regulatory Information for XENAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharms North XENAZINE tetrabenazine TABLET;ORAL 021894-001 Aug 15, 2008 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms North XENAZINE tetrabenazine TABLET;ORAL 021894-002 Aug 15, 2008 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Daiichi Sankyo
Medtronic
AstraZeneca
Moodys
Baxter
Chinese Patent Office
Accenture
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.